| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0079 | 0.9 |